Ignite Creation Date:
2025-12-25 @ 12:34 AM
Ignite Modification Date:
2025-12-25 @ 10:43 PM
Study NCT ID:
NCT04522167
Status:
COMPLETED
Last Update Posted:
2025-11-13
First Post:
2020-08-11
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Efficacy and Safety of the Aflibercept FYB203 Biosimilar in Comparison to Eylea® in Patients With Neovascular Age-Related Macular Degeneration
Sponsor:
Bioeq GmbH
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-07-21
Start Date Type:
ACTUAL
Primary Completion Date:
2022-06-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-05-18
Completion Date Type:
ACTUAL
First Submit Date:
2020-08-11
First Submit QC Date:
None
Study First Post Date:
2020-08-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-08-08
Results First Submit QC Date:
None
Results First Post Date:
2025-11-13
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-31
Last Update Post Date:
2025-11-13
Last Update Post Date Type:
ESTIMATED